Methods for diagnosing systemic lupus erythematosus
US11885812B2 · kind B2 · utility
1Cited by
11References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2023 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Sep 13, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are methods of diagnosing and monitoring disease activity and response to treatment in patients having systemic lupus erythematosus using panels of biomarkers, such as at least one biomarker selected from the group consisting of B-lymphocyte-bound C4d, erythrocyte-bound C4d, platelet-bound C4d, and erythrocyte complement receptor type 1, and one further biomarker selected from the group consisting of anti-MCV antibody and anti-nuclear antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.